Dysfunction of Soluble Guanylyl Cyclase in Aorta and Kidney of Goto–Kakizaki Rats: Influence of Age and Diabetic State
Tài liệu tham khảo
Gress, 2000, Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus, N. Engl. J. Med., 342, 905, 10.1056/NEJM200003303421301
Johnstone, 1993, Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus, Circulation, 88, 2510, 10.1161/01.CIR.88.6.2510
Watts, 1996, Impaired endothelium-dependent and independent dilation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: Role of dyslipidaemia, Clin. Sci. (Colch.), 91, 567, 10.1042/cs0910567
Yuen, 1990, A new form of guanylyl cyclase is preferentially expressed in rat kidney, Biochemistry, 29, 10872, 10.1021/bi00501a002
Goto, 1981, The spontaneous-diabetes rat: A model of noninsulin dependent diabetes mellitus, Proc. Jpn. Acad., 57, 381, 10.2183/pjab.57.381
Portha, 1991, Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes, Diabetes, 40, 486, 10.2337/diab.40.4.486
Farese, 1994, Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto–Kakizaki rats, Proc. Natl. Acad. Sci. USA, 91, 11040, 10.1073/pnas.91.23.11040
Valensi, 1996, Rhéologie érythrocytaire et hypertrophie cardiaque au cours du diabète sucré, J. Mal. Vasc., 21, 185
Yamashita, 1996, Insulin resistance and body fat distribution, Diabetes Care, 19, 287, 10.2337/diacare.19.3.287
Witte, 1995, Contribution of the nitric oxide–guanylyl cyclase system to circadian regulation of blood pressure in normotensive Wistar–Kyoto rats, Cardiovasc. Res., 30, 682, 10.1016/0008-6363(95)00072-0
Ignarro, 1987, Activation of purified guanylate cyclase by arachidonic acid requires absence of enzyme-bound heme, Biochim. Biophys. Acta, 928, 160, 10.1016/0167-4889(87)90117-0
Lemmer, 1993, Circadian blood pressure variation in transgenic hypertensive rats, Hypertension, 22, 97, 10.1161/01.HYP.22.1.97
Mattes, 1991, Pharmfit—A nonlinear fitting program for pharmacology, Chronobiol. Int., 8, 460, 10.3109/07420529109059182
Ackermann, 1997
De Vriese, 2000, Endothelial dysfunction in diabetes, Br. J. Pharmacol., 130, 963, 10.1038/sj.bjp.0703393
Wedel, 1994, Mutation of His-105 in the β1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase, Proc. Natl. Acad. Sci. USA, 91, 2592, 10.1073/pnas.91.7.2592
Friebe, 1997, Functions of conserved cysteines of soluble guanylyl cyclase, Biochemistry, 36, 1194, 10.1021/bi962047w
Nishikawa, 2000, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, 404, 787, 10.1038/35008121
Gupta, 1997, The β2 subunit inhibits stimulation of the α1/β1 form of soluble guanylyl cyclase by nitric oxide, J. Clin. Invest., 100, 1488, 10.1172/JCI119670